Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.
about
Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentRapid Exchange Between Free and Bound States in RNA-Dendrimer Polyplexes: Implications on the Mechanism of Delivery and ReleaseNanotechnology and cancer.Correlating animal and human phase Ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA.Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts.Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release.Self-assembled lipid nanomedicines for siRNA tumor targeting.Targeted gene silencing using RGD-labeled chitosan nanoparticles.The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies.Recent In Vivo Evidences of Particle-Based Delivery of Small-Interfering RNA (siRNA) into Solid TumorsSignificance and applications of nanoparticles in siRNA delivery for cancer therapy.Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.Efficient protection and transfection of small interfering RNA by cationic shell-crosslinked knedel-like nanoparticles.Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna DeliveryMore effective nanomedicines through particle designsiRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNAAdministration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA.Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane.Systemic delivery of siRNA nanoparticles targeting RRM2 suppresses head and neck tumor growth.Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingStore-Operated Ca2+ Channels in Mesangial Cells Inhibit Matrix Protein Expression.Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapiesCoarse-grained model for PEGylated lipids: effect of PEGylation on the size and shape of self-assembled structuresZwitterionic Nanocarrier Surface Chemistry Improves siRNA Tumor Delivery and Silencing Activity Relative to Polyethylene Glycol.The transferrin receptor and the targeted delivery of therapeutic agents against cancer.Journey to the Center of the Cell: Current Nanocarrier Design Strategies Targeting Biopharmaceuticals to the Cytoplasm and NucleusTargeted polymeric therapeutic nanoparticles: design, development and clinical translationPolycation-based nanoparticle delivery for improved RNA interference therapeutics.Applying small RNA molecules to the directed treatment of human diseases: realizing the potential.Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.A dual wavelength-activatable gold nanorod complex for synergistic cancer treatmentNanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice.Zinc Finger Nucleases: Tailor-made for Gene TherapyBalancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivoMolecular dynamics study of the structure and interparticle interactions of polyethylene glycol-conjugated PAMAM dendrimers.Lipid-based systemic delivery of siRNA.Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA.Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspectiveChemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriersNanomaterials for cancer therapy and imaging.
P2860
Q26766128-B46BC637-16EE-4829-997D-38DA336E16EEQ28821628-9E691935-25D4-4206-95F0-1BD4C36ABD94Q30452478-71565AA7-0522-4C98-8AD1-7D855EE52D7DQ30837863-E992AC48-9AE4-46F1-ADC8-C3A1D038E4EAQ33885654-B4854BF4-009D-48FF-97A3-6B7CE787BBBDQ33902253-AF829B1E-8BA2-4868-ADEE-61428746A055Q33907953-8355490D-7B22-4451-B7F6-1EA9C178B70CQ34031859-A2A91C50-7B73-459B-AA84-1694724C5540Q34072375-F19E553B-EEDE-410C-BCEE-F270559F8252Q34165321-DF980A71-FD01-4A3A-AED1-FC3326507E19Q34297263-39D784E6-527E-44FE-9A90-092967EFFDA6Q34447986-257D8B2D-C428-47DD-8C2D-5C0D2F4EDCBCQ34655168-488092BF-E72D-457B-A380-E1C24E215B3CQ34785349-6C9E8B15-90DB-4C68-9712-4BE7B31F4F21Q35106115-386A4765-0E59-4881-8DCD-309C16B4CE1BQ35224125-B81339BB-1ABD-4B2D-A5CE-1473717D1322Q35691719-EC049897-8CD8-44CA-BCDD-2CBC39C5A7C5Q35778918-4408F2A5-F48A-4E8F-BDCD-1C526F233AEDQ35947017-A8E79748-C46E-46F3-B9FB-160C995A197CQ35995110-406DDA45-068C-493E-959B-9A0200C32B27Q36223317-7496208A-FF7D-450D-9284-844F02365569Q36254445-2EA63522-40C3-4F76-94A3-82A30522B47FQ36290628-4CB7B6D1-E517-4574-9A64-F88B8B4D5E82Q36382827-5DE11449-CA5A-4356-910B-7C4E7FD5921DQ36406637-F1B77241-2CF5-48B4-A09A-0B7EBD25A3E5Q36689670-B1808232-7167-4A54-8FD6-E54BD33E207EQ36934007-0C94FC88-E0FE-4374-8CF3-48D5A81BC427Q37012046-27772794-2015-45AE-B981-FE380397BA8DQ37030891-C601CC22-FD32-41E6-9B7F-0B2B09449FB5Q37036373-30F213A6-59B5-4A93-BD99-7DC1B5F59EBFQ37206530-7CACE613-2AFA-4991-A0E0-6D9DA342CC84Q37241328-88E9F21C-019B-45B7-AA88-A37602494DA4Q37241457-4386DE76-9F4C-412D-9EC6-922B8CAAC818Q37378292-A853249B-D408-43B3-8AAD-AD22187D7139Q37409520-7F13BD1D-BAA9-4204-A131-DBCB0B898F4CQ37425606-25FA53E9-4606-441A-9EDA-40266E3BCD2BQ37444136-11E96046-91BA-4CDD-A0E0-11DE3ABA3F29Q37454370-ACC147E2-D47C-4304-B2BD-B8287FA0795AQ37491231-729CD999-779B-4529-86CC-F385C77D22FEQ37601740-B882EE07-9C39-4F3C-AA56-B59AFDEA7CC4
P2860
Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Physicochemical and biological ...... acid-containing nanoparticles.
@en
type
label
Physicochemical and biological ...... acid-containing nanoparticles.
@en
prefLabel
Physicochemical and biological ...... acid-containing nanoparticles.
@en
P2860
P356
P1476
Physicochemical and biological ...... acid-containing nanoparticles.
@en
P2093
Derek W Bartlett
Mark E Davis
P2860
P304
P356
10.1021/BC0603539
P577
2007-02-28T00:00:00Z